Prot #VS-0145-225: A Muti-Center, Phase 2, Open Label, Parallel Cohort Study of Efficacy and Safety of Duvelisib in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Project: Research project

StatusActive
Effective start/end date8/6/188/6/21

Funding

  • Parexel (Prot #VS-0145-225)
  • Verastem, Inc. (Prot #VS-0145-225)